Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection.
about
Herbal medicines for treating HIV infection and AIDSDetection of hepatitis C virus in the nasal secretions of an intranasal drug-userThyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspectiveHepatitis C virus infection in san francisco’s HIV-infected urban poorUnderlying Pathophysiology of HCV Infection in HIV-Positive Drug UsersManagement of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical reviewHigh prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in ChinaTreatment optimization for HIV/HCV co-infected patients.Challenges in the treatment of HIV and HCV coinfection.Factors Influencing Uptake of Rapid HIV and Hepatitis C Screening Among Drug Misusing Adult Emergency Department Patients: Implications for Future HIV/HCV Screening Interventions.Bayesian semiparametric regression for longitudinal binary processes with missing data.Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study.Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.Interleukin-27 is differentially associated with HIV viral load and CD4+ T cell counts in therapy-naïve HIV-mono-infected and HIV/HCV-co-infected ChineseNeurocognitive effects of HIV, hepatitis C, and substance use historyOutcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response.A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patientsIL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapyCoinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons.HCV chronic hepatitis in patients with HIV: clinical management issues.Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection.Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.Hepatitis C: magnitude of the problem.Hepatitis C and human immunodeficiency virus infection.Socio-Economic Status Determines Risk of Receptive Syringe Sharing Behaviors among Iranian Drug Injectors; A National StudySocial determinants of health associated with hepatitis C co-infection among people living with HIV: results from the Positive Spaces, Healthy Places study.HIV and HCV coinfection in haemophilia.The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre.Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV/HCV who have alcohol problemsGenotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional studyLiver enzymes elevation after HAART in HIV-HCV co-infection.Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis.Coinfection with HIV and hepatitis C virus in injection drug users and minority populations.Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.Treatment of hepatitis C in HIV-coinfected patients.HIV and HCV coinfected haemophilia patients: what are the best options of orthopaedic treatment?Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, NigeriaTriple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.Relationship of Oxidative Stress with HIV Disease Progression in HIV/HCV Co-infected and HIV Mono-infected Adults in Miami.
P2860
Q24246643-7E9D8CE7-7E62-40AD-92DE-379C7A80932BQ24792631-FCFE50B9-CFF6-420D-BFEA-910D321BBFC4Q26827517-ED9B23BA-E076-4079-9B13-B66D9D764067Q27473306-A6955378-1CFD-4B8D-A490-11A490827840Q27489073-BC289D17-8779-485C-B8C8-2C1CEF1161F7Q27489337-72BE9724-DE82-44BE-83D3-068EC9EB7024Q28474105-D1439F18-71F5-479E-B344-BFCAD18C0332Q30235034-8FC26728-C8FE-4D22-8101-D2B2244D8C4CQ30389282-AE930BED-11F1-4F2C-A85E-B478309E7D2EQ30667479-C742E200-BCE7-4A49-AE4F-30B6BC7E218FQ31150079-15B90DB5-D4DB-4C01-928D-2C6158380B7AQ33492589-6DBF4805-8E22-4E33-AC1B-148E23448523Q33585762-FF94A0C1-1850-4A7F-A750-F670675F6E77Q33590441-AB5DFDFF-E715-4277-B404-DE9875799DB5Q33652957-3B997E60-E02F-4434-A7E3-5AC19745352AQ33821728-E199A78C-5DC3-481F-9BE4-4DCC6017311AQ33999798-8F3896C6-CDD4-408D-BC52-52E0D322DD0AQ34049322-4E854BBC-5443-422B-8F1C-205A6D8AAB43Q34279897-4807C614-776F-4775-8E50-CE4004ED6E8BQ34565853-1E1929D0-7F44-439F-8396-15B8577EC5C9Q34756205-8E584A28-BFDF-4219-A30D-E17708F503B5Q34849390-70938E82-361A-4D54-9722-6B0E924B49B0Q34873114-F74F3602-EE6A-47FD-8CA0-CA6AFBF03163Q34936115-8ACBC7FA-B973-41E4-9EEC-0894DCFFAE0BQ34984125-0D23B557-5C29-402F-BB72-0E981F37671BQ35206950-17C7E16A-C7A2-4425-8E96-2E0E3F336CD2Q35496965-9509ECD8-A529-4580-97AA-BD532CB0AE20Q35666754-7789FB7A-5926-4A8F-B13F-707D72B76252Q36011960-E567A555-9E66-455A-B992-0EB1716578B9Q36016477-0723DDD5-0453-42F9-8272-54EAE7731EF3Q36110233-A6327F70-121D-4A65-8042-8C55D430CADFQ36177726-515B4D68-608F-4CDA-A819-154377855E44Q36218336-8FE92613-F28A-434E-8860-7A7AD7874A1EQ36304424-B6AA4551-6CA9-4F45-8532-364A98A97077Q36375990-D2AA6598-CEBB-4E0B-B8FD-901B382994FFQ36409500-A1A0AEA8-DCDC-46BB-B1B4-D0D3BEADB367Q36473069-42F681F8-A9BC-4ED6-BBF0-92BFA16B27EBQ36569758-C2AAA01E-8C5B-425C-A42F-8468A9DAAFF6Q36612848-2D02E152-B4F5-40DF-812D-4E77AA2EB8F4Q36680651-A8860288-7F06-4FD3-99A6-4E2BFFE6CE20
P2860
Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Hepatitis C virus infection-re ...... unodeficiency virus infection.
@en
Hepatitis C virus infection-re ...... unodeficiency virus infection.
@nl
type
label
Hepatitis C virus infection-re ...... unodeficiency virus infection.
@en
Hepatitis C virus infection-re ...... unodeficiency virus infection.
@nl
prefLabel
Hepatitis C virus infection-re ...... unodeficiency virus infection.
@en
Hepatitis C virus infection-re ...... unodeficiency virus infection.
@nl
P2093
P2860
P356
P1476
Hepatitis C virus infection-re ...... unodeficiency virus infection.
@en
P2093
Rodriguez-Barradas MC
P2860
P304
P356
10.1086/321819
P407
P577
2001-06-15T00:00:00Z